Arbutus Biopharma (ABUS) Preferred Dividend Payments (2017 - 2021)

Arbutus Biopharma has reported Preferred Dividend Payments for 5 years, with the latest figure at $574000.0 in Q4 2021.

• Quarterly Preferred Dividend Payments fell 81.62% year-over-year to $574000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $574000.0 (down 96.09% YoY) and the FY2021 annual result came in at $12.1 million, changed 0.13% from the prior year.
• Preferred Dividend Payments slipped to $574000.0 in Q4 2021 per ABUS's latest filing, from $5.1 million in the prior quarter.
• Over five years, Preferred Dividend Payments peaked at $5.1 million in Q3 2021 and troughed at $574000.0 in Q4 2021.
• A 5-year average of $2.7 million and a median of $2.8 million in 2019 frame the typical range for Preferred Dividend Payments.
• The sharpest annual moves came in 2018 and 2021: Preferred Dividend Payments soared 190.56% in 2018, then tumbled 81.62% in 2021.
• Over 5 years, Preferred Dividend Payments stood at $911000.0 in 2017, then surged by 190.56% to $2.6 million in 2018, then increased by 8.8% to $2.9 million in 2019, then gained by 8.44% to $3.1 million in 2020, then plunged by 81.62% to $574000.0 in 2021.
• According to Business Quant data, Preferred Dividend Payments over the past three periods registered $574000.0, $5.1 million, and $3.3 million for Q4 2021, Q3 2021, and Q2 2021 respectively.